Adipose tissue: - An alternative source for therapeutic angiogenesis

Circulation Journal

Volumn 76, Issue 7, 2012, Pages 1597-1598

  Takahashi, Masafumi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ADIPOSE TISSUE; ANGIOGENESIS; BUERGER DISEASE; CRITICAL LIMB ISCHEMIA; DISEASE EXACERBATION; EDITORIAL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; PAIN ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PULMONARY ARTERIOVENOUS FISTULA; SKIN ULCER; SUDDEN DEATH; THERAPY EFFECT; TREATMENT OUTCOME;

ADIPOSE TISSUE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG ULCER; LOWER EXTREMITY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION;

EID: 84863226486     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0641     Document Type: Editorial

References (15)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cellbased therapy in ischaemic heart disease: Promise, uncertainties, and challenges. Eur Heart J 2011; 32: 1197-1206.
3. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S, et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006; 98: 1194-1202.
4. Shiba Y, Takahashi M, Hata T, Murayama H, Morimoto H, Ise H, et al. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis. Cardiovasc Res 2009; 81: 169-177.
5. Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006; 24: 1620-1626.
6. Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res 2009; 12: 359-366.
7. Murohara T. Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis. J Cardiol 2009; 53: 155-163.
8. Chen Y, Wang G, Zeng L. Adipose tissue or bone marrow, store for purchasing mesenchymal stem cells? Circ J 2011; 75: 2060-2061.
9. Lee HC, An SG, Lee HW, Park JS, Cha KS, Hong TJ, et al. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: A pilot study. Circ J 2012; 76: 1750-1760.
10. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009; 54: 2277-2286.
11. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 92-95.
12. Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, Imaizumi M, et al. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 2009; 29: 61-66.
13. Takahashi M. Role of the SDF-1/CXCR4 system in myocardial infarction. Circ J 2010; 74: 418-423.
14. Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006; 114: 2679-2684.
15. Takahashi M, Izawa A, Ishigatsubo Y, Fujimoto K, Miyamoto M, Horie T, et al. Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseases. Curr Pharm Des 2009; 15: 2778-2783.